Clinical trials recruiting in Australia

910 clinical trials are currently recruiting with Australian sites across 92 conditions. Each links to a plain English summary and back to its original registry record, where you can verify the current status directly. A trial that covers more than one condition appears under each.

Alopecia Areata

5 recruiting in Australia

• NCT05723198Phase 3 Eli Lilly and Company
• NCT06012240Phase 3 AbbVie
• NCT07205159Phase 1 Forte Biosciences, Inc.
• NCT07317544Phase 2 Absci Pty Ltd.
• NCT07327359Phase 2 Olix Pharmaceuticals, Inc.

Alzheimer's Disease

14 recruiting in Australia

• NCT00869817Not Applicable Washington University School of Medicine
• NCT05194787Not Applicable University of Tasmania
• NCT05552157Phase 3 Washington University School of Medicine
• NCT06339190Not Applicable Monash University
• NCT06647498Phase 3 Washington University School of Medicine
• NCT06976203Phase 3 Bristol-Myers Squibb
• NCT06976216Phase 3 Bristol-Myers Squibb
• NCT07033494Phase 2 Merck Sharp & Dohme LLC
• NCT07094516Phase 2 Novartis Pharmaceuticals
• NCT07105709Phase 2 GlaxoSmithKline
• NCT07170150Phase 3 Hoffmann-La Roche
• NCT07177352Phase 3 Hoffmann-La Roche
• NCT07598370Phase 1 Eli Lilly and Company
• NCT07660341Phase 1 ChainGen Biopharma Ltd

Ankylosing Spondylitis

1 recruiting in Australia

• NCT07047703Phase 2 Grey Wolf Therapeutics

Asthma

4 recruiting in Australia

• NCT05757102Phase 3 GlaxoSmithKline
• NCT07055542Not Applicable University of Melbourne
• NCT07245368Phase 2 Prana Therapies Inc
• NCT07309614Phase 3 Université de Sherbrooke

Atrial Fibrillation

6 recruiting in Australia

• NCT03968393Phase 4 Population Health Research Institute
• NCT06324188Not Applicable Atrial Fibrillation Network
• NCT06455098Not Applicable Biosense Webster, Inc.
• NCT06735534Not Applicable Boston Scientific Corporation
• NCT07298473Not Applicable Medtronic Cardiac Ablation Solutions
• NCT07726056Not Applicable University Hospital of Leuven Leuven

Autism Spectrum Disorder

2 recruiting in Australia

• NCT05590715Not Applicable Stalicla SA
• NCT07167732Not Applicable University Medical Centre Ljubljana

Bipolar Disorder

2 recruiting in Australia

• NCT06929273Phase 3 Bristol-Myers Squibb
• NCT06951698Phase 3 Bristol-Myers Squibb

Bladder Cancer

20 recruiting in Australia

• NCT04564781Not Applicable Cedars-Sinai Medical Center
• NCT04585750Phase 2 PMV Pharmaceuticals, Inc
• NCT04752722Phase 2 enGene, Inc.
• NCT04879329Phase 2 Seagen, a wholly owned subsidiary of Pfizer
• NCT05080998Not Applicable Pacific Edge Limited
• NCT05483868Phase 1 Aura Biosciences
• NCT05614739Phase 1 Eli Lilly and Company
• NCT05706129Phase 2 ITM Oncologics GmbH
• NCT06172478Phase 2 Daiichi Sankyo
• NCT06351904Phase 1 Ractigen Therapeutics.
• NCT06465069Phase 1 Eli Lilly and Company
• NCT06833073Phase 2 Merck Sharp & Dohme LLC
• NCT06960577Phase 3 AstraZeneca
• NCT06995677Phase 2 Tyra Biosciences, Inc
• NCT07106762Phase 3 Bristol-Myers Squibb
• NCT07186842Phase 2 BioNTech SE
• NCT07218380Phase 3 Eli Lilly and Company
• NCT07419295Phase 3 Merck Sharp & Dohme LLC
• NCT07421700Phase 2 Pfizer
• NCT07660055Phase 1 Novartis Pharmaceuticals

Brain Cancer

13 recruiting in Australia

• NCT00196742Not Applicable Genzyme, a Sanofi Company
• NCT04684368Phase 2 Children's Oncology Group
• NCT05009992Phase 2 University of California, San Francisco
• NCT05230758Phase 3 Donald Mabbott
• NCT05450744Phase 1 Telix Pharmaceuticals (Innovations) Pty Limited
• NCT05504772Not Applicable Australian & New Zealand Children's Haematology/Oncology Group
• NCT05839379Not Applicable Nationwide Children's Hospital
• NCT05843253Phase 2 Nationwide Children's Hospital
• NCT06838676Phase 2 Nationwide Children's Hospital
• NCT06951659Not Applicable The University of Western Australia
• NCT07100730Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited
• NCT07363057Phase 2 GI Innovation, Inc.
• NCT07465796Not Applicable Coherence Neuro Australia Pty Limited

Breast Cancer

22 recruiting in Australia

• NCT04862663Phase 3 AstraZeneca
• NCT05216432Phase 1 Relay Therapeutics, Inc.
• NCT05350722Not Applicable Amsterdam UMC, location VUmc
• NCT05417516Phase 3 Ontario Clinical Oncology Group (OCOG)
• NCT05508906Phase 1 Olema Pharmaceuticals, Inc.
• NCT05633654Phase 3 Gilead Sciences
• NCT05774951Phase 3 AstraZeneca
• NCT05827081Phase 3 Novartis Pharmaceuticals
• NCT05950945Phase 3 Daiichi Sankyo
• NCT05952557Phase 3 AstraZeneca
• NCT06065748Phase 3 Hoffmann-La Roche
• NCT06103864Phase 3 AstraZeneca
• NCT06380751Phase 3 AstraZeneca
• NCT06757634Phase 3 Celcuity Inc
• NCT06982521Phase 3 Relay Therapeutics, Inc.
• NCT07060807Phase 3 Merck Sharp & Dohme LLC
• NCT07062965Phase 3 Pfizer
• NCT07085767Phase 3 Olema Pharmaceuticals, Inc.
• NCT07222267Phase 1 BeOne Medicines
• NCT07358377Phase 1 Atridia Pty Ltd.
• NCT07413939Phase 3 Hoffmann-La Roche
• NCT07492641Phase 3 BeOne Medicines

Cardiomyopathy

6 recruiting in Australia

• NCT05164328Not Applicable Universitaire Ziekenhuizen KU Leuven
• NCT06128629Phase 3 Intellia Therapeutics
• NCT06360939Not Applicable Western Sydney Local Health District
• NCT06563895Phase 3 Eidos Therapeutics, a BridgeBio company
• NCT07052903Phase 3 Alnylam Pharmaceuticals
• NCT07207811Phase 3 Novo Nordisk A/S

Chronic Kidney Disease

11 recruiting in Australia

• NCT03573089Not Applicable The University of Queensland
• NCT05027906Phase 2 Eledon Pharmaceuticals
• NCT05099770Phase 3 Prokidney
• NCT05196035Phase 3 Bayer
• NCT05457283Phase 3 Bayer
• NCT06310967Phase 2 Intelligem Therapeutics Australia Pty Ltd.
• NCT06531824Phase 3 Boehringer Ingelheim
• NCT06717698Phase 2 Novo Nordisk A/S
• NCT07107945Phase 3 Boehringer Ingelheim
• NCT07231679Phase 2 Ingenia Therapeutics INC
• NCT07577817Early Phase 1 Cajal Therapeutics Inc.

Chronic Rhinosinusitis

1 recruiting in Australia

• NCT05882903Phase 2 Oticara Australia PTY LTD

Coeliac Disease

2 recruiting in Australia

• NCT06982963Phase 2 Forte Biosciences, Inc.
• NCT07239336Phase 2 Chugai Pharmaceutical

Colorectal Cancer

14 recruiting in Australia

• NCT00843375Not Applicable University of Michigan Rogel Cancer Center
• NCT04008407Not Applicable Western Sydney Local Health District
• NCT04929223Phase 1 Hoffmann-La Roche
• NCT05041478Not Applicable Western Sydney Local Health District
• NCT05253651Phase 3 Seagen, a wholly owned subsidiary of Pfizer
• NCT05759728Phase 2 Carina Biotech Limited
• NCT05855200Phase 3 GlaxoSmithKline
• NCT06050707Phase 2 University Health Network, Toronto
• NCT06252649Phase 3 Amgen
• NCT06976710Not Applicable Surgical Outcomes Research Centre (SOuRCe)
• NCT06997497Phase 3 Merck Sharp & Dohme LLC
• NCT07221357Phase 3 Bristol-Myers Squibb
• NCT07235293Phase 2 Kahr Bio Australia Pty Ltd
• NCT07244705Phase 2 Anbogen Therapeutics, Inc.

COPD

8 recruiting in Australia

• NCT04710576Phase 2 Syndax Pharmaceuticals
• NCT05878769Phase 3 Hoffmann-La Roche
• NCT06496620Phase 2 Uniquity One (UNI)
• NCT06585774Phase 3 Incyte Corporation
• NCT06878261Phase 3 AstraZeneca
• NCT06961214Phase 3 GlaxoSmithKline
• NCT06986070Phase 1 SMSbiotech
• NCT07082738Phase 2 AstraZeneca

Crohn's Disease and Colitis

33 recruiting in Australia

• ISRCTN15911581Phase 3 Janssen-Cilag International N.V.
• ISRCTN37514492Phase 3 Janssen-Cilag International NV
• NCT04779320Phase 3 Takeda
• NCT04970446Phase 2 St Vincent's Hospital Melbourne
• NCT05076175Phase 3 Bristol-Myers Squibb
• NCT05442567Phase 3 Takeda
• NCT05469607Not Applicable Austin Health
• NCT05923073Phase 3 Janssen Research & Development, LLC
• NCT06029972Phase 2 Gilead Sciences
• NCT06226883Phase 2 Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
• NCT06233461Phase 2 Takeda
• NCT06257706Phase 4 Alimentiv Inc.
• NCT06332534Phase 3 AbbVie
• NCT06430801Phase 3 Merck Sharp & Dohme LLC
• NCT06588855Phase 3 Hoffmann-La Roche
• NCT06619990Phase 2 Xencor, Inc.
• NCT06627556Phase 1 Jiangsu Carephar Pharmaceutical Co., Ltd.
• NCT06637631Phase 2 Sanofi
• NCT06819878Phase 3 Hoffmann-La Roche
• NCT06819891Phase 3 Hoffmann-La Roche
• NCT06850727Phase 2 Odyssey Therapeutics
• NCT06867094Phase 2 Sanofi
• NCT06958536Phase 2 Sanofi
• NCT06975722Phase 2 Sanofi
• NCT06979336Phase 2 Genentech, Inc.
• NCT07012395Phase 2 Spyre Therapeutics, Inc.
• NCT07158242Phase 3 Hoffmann-La Roche
• NCT07184931Phase 3 Sanofi
• NCT07196722Phase 3 Janssen Research & Development, LLC
• NCT07196748Phase 3 Janssen Research & Development, LLC
• NCT07298421Phase 3 Hoffmann-La Roche
• NCT07526519Phase 1 TrueLab Biopharmaceutical Co., Ltd
• NCT07577843Phase 3 Janssen Research & Development, LLC

Cystic Fibrosis

3 recruiting in Australia

• NCT05802264Phase 1 Cystetic Medicines, Inc.
• NCT07035990Phase 1 Sionna Therapeutics Inc.
• NCT07048262Phase 2 CSL Behring

Depression and Anxiety

6 recruiting in Australia

• NCT06938841Not Applicable University of California, San Diego
• NCT07136584Not Applicable Murdoch Childrens Research Institute
• NCT07151079Not Applicable Murdoch Childrens Research Institute
• NCT07196501Phase 3 Neurocrine Biosciences
• NCT07270029Not Applicable Telethon Kids Institute
• NCT07412756Phase 3 Eli Lilly and Company

Eating Disorders

2 recruiting in Australia

• NCT05788042Not Applicable The George Institute
• NCT06594913Not Applicable University of North Carolina, Chapel Hill

Eczema

7 recruiting in Australia

• NCT05995964Phase 2 Pfizer
• NCT06241118Phase 3 Sanofi
• NCT06461897Phase 3 AbbVie
• NCT06584552Phase 2 The University of New South Wales
• NCT06808477Phase 1 Bambusa Therapeutics
• NCT06855745Phase 2 Alphyn Biologics
• NCT06934252Phase 1 TRex Bio, Inc.

Endometrial Cancer

9 recruiting in Australia

• NCT04073706Phase 3 Queensland Centre for Gynaecological Cancer
• NCT05640999Phase 2 Canadian Cancer Trials Group
• NCT06153667Not Applicable Merit Medical Systems, Inc.
• NCT06278857Phase 2 Queensland Centre for Gynaecological Cancer
• NCT06340568Phase 3 BioNTech SE
• NCT06432478Not Applicable Royal North Shore Hospital
• NCT07044336Phase 3 AstraZeneca
• NCT07166094Phase 3 Genmab
• NCT07286331Phase 3 GlaxoSmithKline

Epilepsy

13 recruiting in Australia

• NCT05219617Phase 3 SK Life Science, Inc.
• NCT05419492Phase 2 Encoded Therapeutics
• NCT05518578Phase 2 Supernus Pharmaceuticals, Inc.
• NCT05667142Phase 3 Xenon Pharmaceuticals Inc.
• NCT05716100Phase 3 Xenon Pharmaceuticals Inc.
• NCT05947656Not Applicable Genovate-NaviFUS (Australia) Pty Ltd.
• NCT06401538Phase 2 Bright Minds Biosciences Pty Ltd
• NCT06660394Phase 3 Longboard Pharmaceuticals
• NCT06908356Phase 2 Praxis Precision Medicines
• NCT07010471Phase 3 Praxis Precision Medicines
• NCT07156201Phase 1 Actio Biosciences, Inc.
• NCT07238868Phase 2 Shanghai Zhimeng Biopharma, Inc.
• NCT07640191Not Applicable iVEAcare

Friedreich Ataxia

2 recruiting in Australia

• NCT06874010Phase 2 Design Therapeutics, Inc.
• NCT06953583Phase 3 Biogen

Gastro-oesophageal Reflux Disease

1 recruiting in Australia

• NCT06839248Not Applicable St Vincent's Hospital Melbourne

Gastroparesis

3 recruiting in Australia

• NCT06401746Not Applicable University of Western Sydney
• NCT06411574Not Applicable University of Western Sydney
• NCT06854120Not Applicable University of Auckland, New Zealand

Gaucher Disease

3 recruiting in Australia

• NCT00358943Not Applicable Genzyme, a Sanofi Company
• NCT05487599Phase 2 Prevail Therapeutics
• NCT07223944Phase 3 Spur Therapeutics

Glaucoma

1 recruiting in Australia

• NCT06833060Not Applicable Lumibird Medical (Quantel Medical, Ellex Medical, Optotek)

Gout

1 recruiting in Australia

• NCT07145229Phase 2 Atom Therapeutics Co., Ltd

Haemophilia

5 recruiting in Australia

• NCT05145127Phase 3 Pfizer
• NCT05568719Phase 3 Pfizer
• NCT05611801Phase 3 Pfizer
• NCT06003387Phase 3 CSL Behring
• NCT06379789Phase 2 Regeneron Pharmaceuticals

Head and Neck Cancer

7 recruiting in Australia

• NCT04266223Not Applicable University of Sydney
• NCT04534205Phase 3 BioNTech SE
• NCT04901234Phase 2 Centre hospitalier de l'Université de Montréal (CHUM)
• NCT05025813Phase 2 Queensland Health
• NCT06029270Phase 2 National Cancer Institute (NCI)
• NCT06256588Phase 3 GlaxoSmithKline
• NCT06525220Phase 3 Merus B.V.

Hearing Loss

5 recruiting in Australia

• NCT05572073Not Applicable Akouos, Inc.
• NCT05847426Not Applicable The Bionics Institute of Australia
• NCT06098482Not Applicable Cochlear
• NCT06580847Not Applicable Toronto Metropolitan University
• NCT07572357Not Applicable Rehear Audiology Company LTD

Heart Disease

14 recruiting in Australia

• NCT03998319Phase 3 University of Sydney
• NCT04124120Not Applicable Weill Medical College of Cornell University
• NCT04983823Not Applicable Baker Heart and Diabetes Institute
• NCT05325034Not Applicable Stephen Nicholls
• NCT05366153Not Applicable Baker Heart and Diabetes Institute
• NCT05636176Phase 3 Novo Nordisk A/S
• NCT06056297Phase 3 X4 Pharmaceuticals
• NCT06118281Phase 3 Novo Nordisk A/S
• NCT06164730Phase 1 Verve Therapeutics, Inc.
• NCT06700720Phase 2 Beijing Inno Medicine Co., Ltd.
• NCT06813339Early Phase 1 Cyclarity Therapeutics, Inc.
• NCT06959524Not Applicable Boston Scientific Corporation
• NCT07136012Phase 3 Amgen
• NCT07293260Phase 3 Amgen

Hepatitis B

5 recruiting in Australia

• NCT04914611Not Applicable Kirby Institute
• NCT06277037Not Applicable Arbutus Biopharma Corporation
• NCT07024641Phase 1 GigaGen, Inc.
• NCT07059403Phase 1 Chimivac INC
• NCT07370207Phase 2 AusperBio Therapeutics Inc.

Hepatitis C

4 recruiting in Australia

• NCT03685045Not Applicable Kirby Institute
• NCT05042544Not Applicable Kirby Institute
• NCT05248555Not Applicable Kirby Institute
• NCT05713136Not Applicable Kirby Institute

HIV and AIDS

1 recruiting in Australia

• NCT07202546Phase 2 ViiV Healthcare

Huntington's Disease

3 recruiting in Australia

• NCT01574053Not Applicable CHDI Foundation, Inc.
• NCT05509153Phase 2 Western Sydney Local Health District
• NCT07246941Phase 1 Hoffmann-La Roche

Hypertension

6 recruiting in Australia

• NCT06059638Not Applicable Orchestra BioMed, Inc
• NCT06907147Not Applicable Medtronic Vascular
• NCT07181109Phase 3 Alnylam Pharmaceuticals
• NCT07282171Phase 1 Comanche Biopharma
• NCT07428473Phase 1 Monash University
• NCT07555574Not Applicable Center for Eye Research Australia

Interstitial Lung Disease

21 recruiting in Australia

• NCT04676828Not Applicable University of Aarhus
• NCT05828069Phase 2 National Cancer Institute (NCI)
• NCT05878717Phase 3 GlaxoSmithKline
• NCT05943535Phase 3 United Therapeutics
• NCT06122233Not Applicable University of Sydney
• NCT06159660Not Applicable University of Sydney
• NCT06238622Phase 3 Boehringer Ingelheim
• NCT06572384Phase 3 GlaxoSmithKline
• NCT06626438Not Applicable The University of Western Australia
• NCT06806592Phase 3 Boehringer Ingelheim
• NCT06855329Not Applicable University of Massachusetts, Worcester
• NCT06951217Phase 2 Avalyn Pharma Inc.
• NCT06967805Phase 2 Mediar Therapeutics
• NCT06968845Phase 2 Rein Therapeutics
• NCT07036523Phase 2 Boehringer Ingelheim
• NCT07194382Phase 2 Avalyn Pharma Inc.
• NCT07201922Phase 3 Boehringer Ingelheim
• NCT07284459Phase 2 Contineum Therapeutics
• NCT07366034Phase 3 Boehringer Ingelheim
• NCT07454291Phase 1 Endeavor Biomedicines, Inc.
• NCT07652658Phase 2 AstraZeneca

Irritable Bowel Syndrome

2 recruiting in Australia

• NCT05274854Not Applicable The University of Queensland
• NCT06940596Not Applicable University of Melbourne

Kidney Cancer

15 recruiting in Australia

• NCT03394365Phase 3 Pierre Fabre Medicament
• NCT04322318Phase 2 Children's Oncology Group
• NCT05327686Phase 2 NRG Oncology
• NCT05536141Phase 1 Arcus Biosciences, Inc.
• NCT05868174Phase 1 Telix Pharmaceuticals (Innovations) Pty Limited
• NCT06368817Phase 2 Children's Oncology Group
• NCT06401330Phase 3 Children's Oncology Group
• NCT06764771Phase 1 Bristol-Myers Squibb
• NCT07006688Phase 1 Servier Bio-Innovation LLC
• NCT07011719Phase 3 Arcus Biosciences, Inc.
• NCT07197580Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited
• NCT07227402Phase 3 Merck Sharp & Dohme LLC
• NCT07227415Phase 2 Pfizer
• NCT07293351Phase 2 Bristol-Myers Squibb
• NCT07489495Phase 3 Merck Sharp & Dohme LLC

Leukaemia

40 recruiting in Australia

• NCT01281735Not Applicable Poitiers University Hospital
• NCT01804686Phase 3 Janssen Research & Development, LLC
• NCT02966756Phase 2 AbbVie
• NCT03643276Phase 3 Martin Schrappe
• NCT04293562Phase 3 Children's Oncology Group
• NCT04581512Phase 2 Ellipses Pharma
• NCT04771130Phase 2 BeOne Medicines
• NCT04811560Phase 2 Janssen Research & Development, LLC
• NCT04895436Phase 2 AbbVie
• NCT04996875Phase 2 Cogent Biosciences, Inc.
• NCT05091424Phase 1 Hoffmann-La Roche
• NCT05183035Phase 3 PedAL BCU, LLC
• NCT05254743Phase 3 Loxo Oncology, Inc.
• NCT05304377Phase 1 Enliven Therapeutics
• NCT05475925Phase 2 Dren Bio
• NCT05476770Phase 1 Therapeutic Advances in Childhood Leukemia Consortium
• NCT05636514Phase 1 Clinical Hub for Interventional Research (CHOIR)
• NCT05756322Phase 2 Lin BioScience, Inc
• NCT06051409Phase 3 Ascentage Pharma Group Inc.
• NCT06104566Phase 3 Ascentage Pharma Group Inc.
• NCT06136559Phase 3 Merck Sharp & Dohme LLC
• NCT06163430Phase 2 Terns, Inc.
• NCT06366789Phase 1 Lomond Therapeutics Holdings, Inc.
• NCT06372717Phase 1 Apollo Therapeutics Ltd
• NCT06395103Phase 2 Merck Sharp & Dohme LLC
• NCT06428019Phase 3 AbbVie
• NCT06456463Phase 2 Stemline Therapeutics, Inc.
• NCT06656494Phase 1 Beijing InnoCare Pharma Tech Co., Ltd.
• NCT06812715Phase 2 Peter MacCallum Cancer Centre, Australia
• NCT06846671Phase 3 BeOne Medicines
• NCT06852222Phase 3 Janssen Research & Development, LLC
• NCT06876649Phase 4 Eli Lilly and Company
• NCT06943872Phase 3 BeOne Medicines
• NCT07051525Not Applicable Peter MacCallum Cancer Centre, Australia
• NCT07155226Phase 2 AstraZeneca
• NCT07211958Phase 3 Syndax Pharmaceuticals
• NCT07277231Phase 3 BeOne Medicines
• NCT07306832Phase 1 AbbVie
• NCT07354074Phase 2 Novartis Pharmaceuticals
• NCT07527221Phase 1 Eilean Therapeutics AU Pty Ltd

Liver Cancer

10 recruiting in Australia

• NCT04075305Not Applicable UMC Utrecht
• NCT04455932Not Applicable Concord Repatriation General Hospital
• NCT05428735Not Applicable Maastricht University
• NCT06252753Not Applicable AstraZeneca
• NCT06478693Phase 1 Myeloid Therapeutics
• NCT06921785Phase 3 AstraZeneca
• NCT06923761Phase 2 Grey Wolf Therapeutics
• NCT07291076Phase 2 Bristol-Myers Squibb
• NCT07391670Phase 1 AstraZeneca
• NCT07628751Not Applicable University Health Network, Toronto

Long COVID

1 recruiting in Australia

• NCT07661862Not Applicable University of Tasmania

Lung Cancer

31 recruiting in Australia

• NCT02468024Phase 3 University of Texas Southwestern Medical Center
• NCT04613596Phase 3 Mirati Therapeutics Inc.
• NCT04928846Phase 3 AbbVie
• NCT05235165Phase 3 Children's Oncology Group
• NCT05789082Phase 2 Hoffmann-La Roche
• NCT05920356Phase 3 Amgen
• NCT06119581Phase 3 Eli Lilly and Company
• NCT06343402Phase 1 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
• NCT06357533Phase 3 AstraZeneca
• NCT06452277Phase 3 Bayer
• NCT06613009Phase 1 Innovent Biologics (Suzhou) Co. Ltd.
• NCT06625775Phase 1 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
• NCT06692738Phase 3 AstraZeneca
• NCT06712316Phase 3 BioNTech SE
• NCT06712355Phase 3 BioNTech SE
• NCT06716437Not Applicable University of Melbourne
• NCT06855771Phase 2 Bristol-Myers Squibb
• NCT06868277Phase 3 AstraZeneca
• NCT06875310Phase 3 Mirati Therapeutics Inc.
• NCT06881784Phase 3 Revolution Medicines, Inc.
• NCT06905197Phase 1 Dizal Pharmaceuticals
• NCT07005102Phase 3 AbbVie
• NCT07005128Phase 3 Amgen
• NCT07063745Phase 3 Bristol-Myers Squibb
• NCT07099898Phase 3 GlaxoSmithKline
• NCT07144280Phase 3 Pfizer
• NCT07174583Phase 2 IDEAYA Biosciences
• NCT07226999Phase 3 Pfizer
• NCT07288177Phase 2 Genmab
• NCT07361497Phase 3 Bristol-Myers Squibb
• NCT07472517Phase 3 Boehringer Ingelheim

Lupus

14 recruiting in Australia

• NCT03138941Not Applicable Monash University
• NCT06133972Phase 3 Novartis Pharmaceuticals
• NCT06557265Phase 2 Nkarta, Inc.
• NCT06570798Phase 2 Amgen
• NCT06581198Phase 2 Novartis Pharmaceuticals
• NCT06613360Phase 1 Cullinan Therapeutics Inc.
• NCT06625671Phase 2 DualityBio Inc.
• NCT06647069Phase 1 Sanofi
• NCT06897930Phase 2 AstraZeneca
• NCT07115745Phase 1 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
• NCT07276958Phase 1 Eli Lilly and Company
• NCT07409181Phase 2 Boehringer Ingelheim
• NCT07438496Phase 3 Janssen Research & Development, LLC
• NCT07491900Phase 1 Hinge Bio

Lymphoma

39 recruiting in Australia

• NCT01790152Not Applicable Children's Oncology Group
• NCT03557619Phase 1 AbbVie
• NCT03666000Phase 1 Imugene Limited
• NCT04065399Phase 2 Syndax Pharmaceuticals
• NCT04546399Phase 2 National Cancer Institute (NCI)
• NCT04728893Phase 2 Merck Sharp & Dohme LLC
• NCT04870944Phase 2 Children's Oncology Group
• NCT04920617Phase 2 ImmunoVaccine Technologies, Inc. (IMV Inc.)
• NCT05180097Phase 2 Canadian Cancer Trials Group
• NCT05279300Phase 1 CStone Pharmaceuticals
• NCT05512390Phase 1 AbbVie
• NCT05659732Phase 1 PharmaEngine
• NCT05826535Phase 2 Lyell Immunopharma, Inc.
• NCT05833763Phase 2 Australasian Leukaemia and Lymphoma Group
• NCT05947851Phase 3 Merck Sharp & Dohme LLC
• NCT05991388Phase 3 University of Birmingham
• NCT06067347Not Applicable Massachusetts General Hospital
• NCT06091254Phase 3 Regeneron Pharmaceuticals
• NCT06091865Phase 3 Regeneron Pharmaceuticals
• NCT06137144Phase 2 AstraZeneca
• NCT06208657Phase 2 Australian & New Zealand Children's Haematology/Oncology Group
• NCT06383338Phase 1 Murdoch Childrens Research Institute
• NCT06514794Phase 2 Wugen, Inc.
• NCT06528301Phase 1 Umoja Biopharma
• NCT06549595Phase 3 AstraZeneca
• NCT06561048Phase 3 Corvus Pharmaceuticals, Inc.
• NCT06588478Phase 2 Loxo Oncology, Inc.
• NCT06667687Phase 1 AbbVie
• NCT06697184Phase 2 BeOne Medicines
• NCT06717347Phase 3 Merck Sharp & Dohme LLC
• NCT06765109Phase 3 Nuvalent Inc.
• NCT06854653Phase 2 Prescient Therapeutics, Ltd.
• NCT06973187Phase 3 BeOne Medicines
• NCT07082803Phase 1 Treeline Biosciences, Inc.
• NCT07109219Phase 2 AstraZeneca
• NCT07123454Phase 2 AstraZeneca
• NCT07215585Phase 3 AstraZeneca
• NCT07218341Phase 4 Eli Lilly and Company
• NCT07308132Phase 1 Janssen Research & Development, LLC

Macular Degeneration

16 recruiting in Australia

• NCT03683251Phase 3 Hoffmann-La Roche
• NCT04739319Not Applicable Center for Eye Research Australia
• NCT05803785Phase 1 Benobio Co., Ltd.
• NCT06087458Phase 2 Perceive Biotherapeutics, Inc.
• NCT06635148Phase 2 Janssen Research & Development, LLC
• NCT06662162Not Applicable i-Lumen Scientific AUS PTY LTD
• NCT06825702Phase 2 Kiora Pharmaceuticals, Inc.
• NCT06924021Not Applicable University of Wisconsin, Madison
• NCT06990269Phase 2 ADARx Pharmaceuticals, Inc.
• NCT07064759Phase 3 4D Molecular Therapeutics
• NCT07215234Phase 2 Sanofi
• NCT07266584Not Applicable Science Corporation
• NCT07267026Phase 1 Consun Pharmaceutical Group
• NCT07440225Phase 3 EyeBiotech Ltd.
• NCT07441642Phase 2 Novartis Pharmaceuticals
• NCT07668804Phase 2 Theratocular Biotek Co.

Melanoma

34 recruiting in Australia

• NCT02402244Not Applicable Children's Oncology Group
• NCT02821013Phase 3 Canadian Cancer Trials Group
• NCT03340129Phase 2 Melanoma Institute Australia
• NCT03860883Not Applicable Melanoma and Skin Cancer Trials Limited
• NCT03947385Phase 2 IDEAYA Biosciences
• NCT04370587Phase 2 ImmVira Pharma Co. Ltd
• NCT05180942Not Applicable Monash University
• NCT05280314Phase 2 IO Biotech
• NCT05549297Phase 3 Immunocore Ltd
• NCT05570227Not Applicable Peter MacCallum Cancer Centre, Australia
• NCT05727904Phase 3 Iovance Biotherapeutics, Inc.
• NCT06007690Phase 3 Aura Biosciences
• NCT06022029Phase 1 OncoNano Medicine, Inc.
• NCT06060613Phase 2 Obsidian Therapeutics, Inc.
• NCT06112314Phase 3 Immunocore Ltd
• NCT06163820Phase 2 Melanoma and Skin Cancer Trials Limited
• NCT06249048Phase 2 Strand Therapeutics Inc.
• NCT06305962Early Phase 1 Radiopharm Theranostics, Ltd
• NCT06326411Phase 1 Nested Therapeutics, Inc
• NCT06536257Not Applicable Melanoma Institute Australia
• NCT06585410Phase 3 Regeneron Pharmaceuticals
• NCT06697301Phase 3 Eikon Therapeutics
• NCT06767306Phase 2 Melanoma Institute Australia
• NCT06940739Phase 2 Iovance Biotherapeutics, Inc.
• NCT06961006Phase 2 Merck Sharp & Dohme LLC
• NCT06999980Phase 2 Melanoma Institute Australia
• NCT07015190Phase 3 IDEAYA Biosciences
• NCT07049276Not Applicable Melanoma Institute Australia
• NCT07063875Phase 2 St Vincent's Hospital, Sydney
• NCT07076550Phase 1 Alpha-9 Oncology USA Inc.
• NCT07086105Phase 1 Adze Biotechnology Australia Pty Ltd
• NCT07138222Not Applicable Peter MacCallum Cancer Centre, Australia
• NCT07339176Phase 2 Onchilles Pharma Inc
• NCT07421739Not Applicable Aura Biosciences

Mesothelioma

3 recruiting in Australia

• NCT04665206Phase 2 Vivace Therapeutics, Inc
• NCT05086692Phase 2 Medicenna Therapeutics, Inc.
• NCT06535607Phase 2 AstraZeneca

Migraine

3 recruiting in Australia

• NCT05700318Not Applicable ShiraTronics
• NCT06450444Not Applicable Salvia BioElectronics
• NCT06625060Phase 2 Ipsen

Motor Neurone Disease

6 recruiting in Australia

• NCT05136222Not Applicable University of Melbourne
• NCT06126315Phase 3 Mario Negri Institute for Pharmacological Research
• NCT06351592Phase 2 Regeneron Pharmaceuticals
• NCT07369076Phase 2 Nura Bio
• NCT07401121Phase 1 Celosia Therapeutics Pty Ltd
• NCT07533903Not Applicable Synchron, Inc.

Multiple Sclerosis

15 recruiting in Australia

• ISRCTN14048364Phase 3 University College London
• NCT05620940Phase 1 Inventage Lab., Inc.
• NCT05658497Not Applicable Biogen
• NCT06408259Phase 3 Bristol-Myers Squibb
• NCT06617793Phase 2 Novartis Pharmaceuticals
• NCT06655896Phase 2 Novartis Pharmaceuticals
• NCT06675864Phase 2 Novartis Pharmaceuticals
• NCT06735248Phase 2 ModernaTX, Inc.
• NCT06782490Phase 2 Celgene
• NCT06846281Phase 3 Novartis Pharmaceuticals
• NCT07085507Phase 2 Vidya Therapeutics Inc
• NCT07224373Phase 1 AstraZeneca
• NCT07225504Phase 3 Novartis Pharmaceuticals
• NCT07282574Phase 2 Hoffmann-La Roche
• NCT07369505Phase 1 SAPU NANO (US) LLC

Muscular Dystrophy

10 recruiting in Australia

• NCT05004129Phase 3 AMO Pharma Limited
• NCT05481879Phase 2 Dyne Therapeutics
• NCT05996003Phase 2 NS Pharma, Inc.
• NCT06131983Phase 2 Arrowhead Pharmaceuticals
• NCT06138743Phase 2 Arrowhead Pharmaceuticals
• NCT06185764Phase 2 Vertex Pharmaceuticals Incorporated
• NCT06844214Phase 2 Sanofi
• NCT06847282Not Applicable University of Kansas Medical Center
• NCT07160634Phase 3 Solid Biosciences Inc.
• NCT07287189Phase 2 Satellos Bioscience, Inc.

Myasthenia Gravis

8 recruiting in Australia

• NCT04951622Phase 3 Janssen Research & Development, LLC
• NCT06193889Phase 3 Kyverna Therapeutics
• NCT06456580Phase 3 Vor Biopharma
• NCT06463587Phase 3 Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
• NCT06517758Phase 3 Novartis Pharmaceuticals
• NCT06744920Phase 3 Novartis Pharmaceuticals
• NCT07304154Phase 1 Kite, A Gilead Company
• NCT07501702Phase 2 Vertex Pharmaceuticals Incorporated

Myeloma

44 recruiting in Australia

• NCT04643002Phase 2 Sanofi
• NCT04973605Phase 2 BeOne Medicines
• NCT05020236Phase 3 Pfizer
• NCT05243797Phase 3 European Myeloma Network B.V.
• NCT05519085Phase 3 Celgene
• NCT05552222Phase 3 Janssen Research & Development, LLC
• NCT05583617Phase 2 Hoffmann-La Roche
• NCT05623020Phase 3 Pfizer
• NCT05666700Phase 1 Peter MacCallum Cancer Centre, Australia
• NCT05678621Phase 3 Monash University
• NCT05714839Phase 2 GlaxoSmithKline
• NCT05730036Phase 3 Regeneron Pharmaceuticals
• NCT05862012Phase 1 Ichnos Sciences SA
• NCT05927571Phase 1 Genentech, Inc.
• NCT06083207Phase 2 Innovent Biologics (Suzhou) Co. Ltd.
• NCT06106945Phase 2 AstraZeneca
• NCT06152575Phase 3 Pfizer
• NCT06158841Phase 3 AbbVie
• NCT06208150Phase 3 Janssen Research & Development, LLC
• NCT06215118Phase 1 Pfizer
• NCT06237803Not Applicable European Myeloma Network B.V.
• NCT06297226Phase 2 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
• NCT06615479Phase 3 Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
• NCT06630806Phase 1 Sanofi
• NCT06669247Phase 2 Regeneron Pharmaceuticals
• NCT06679101Phase 3 GlaxoSmithKline
• NCT06768489Phase 1 Janssen Research & Development, LLC
• NCT06896916Phase 1 AbbVie
• NCT06932562Phase 3 European Myeloma Network B.V.
• NCT06953960Phase 2 AbbVie
• NCT06980480Phase 3 Takeda
• NCT07075185Phase 1 Kelonia Therapeutics, Inc.
• NCT07202052Phase 3 Monash University
• NCT07202065Phase 3 Monash University
• NCT07202078Phase 3 Monash University
• NCT07202091Phase 3 Monash University
• NCT07222761Phase 3 Regeneron Pharmaceuticals
• NCT07258511Phase 3 Janssen Research & Development, LLC
• NCT07391657Phase 3 AstraZeneca
• NCT07455851Phase 2 Regeneron Pharmaceuticals
• NCT07477587Phase 1 Shanghai Henlius Biotech
• NCT07518186Phase 3 Janssen Research & Development, LLC
• NCT07541391Phase 1 Peter MacCallum Cancer Centre, Australia
• NCT07558915Phase 1 Genentech, Inc.

Narcolepsy

5 recruiting in Australia

• NCT05816382Phase 3 Takeda
• NCT06767683Phase 3 Alkermes, Inc.
• NCT07006233Not Applicable University of Sydney
• NCT07455383Phase 3 Alkermes, Inc.
• NCT07633301Phase 2 Takeda

Non-Alcoholic Fatty Liver Disease

9 recruiting in Australia

• NCT05945537Phase 1 Inipharm Australia Pty Ltd
• NCT06215716Phase 3 Akero Therapeutics, Inc
• NCT06318169Phase 3 89bio, Inc.
• NCT06419374Phase 3 89bio, Inc.
• NCT06528314Phase 3 Akero Therapeutics, Inc
• NCT06632444Phase 3 Boehringer Ingelheim
• NCT06632457Phase 3 Boehringer Ingelheim
• NCT07165028Phase 3 Eli Lilly and Company
• NCT07221227Phase 3 GlaxoSmithKline

Obesity

13 recruiting in Australia

• NCT03441451Not Applicable Monash University
• NCT06545435Not Applicable University of Roma La Sapienza
• NCT06859853Phase 1 Shanghai Minwei Biotechnology Co., Ltd
• NCT06894498Not Applicable Boston Scientific Corporation
• NCT06938269Phase 1 Shanghai Minwei Biotechnology Co., Ltd
• NCT07037433Phase 3 Amgen
• NCT07226765Phase 3 Amgen
• NCT07253285Phase 3 Novo Nordisk A/S
• NCT07284875Phase 3 Kailera
• NCT07284901Phase 3 Kailera
• NCT07481630Phase 3 Novo Nordisk A/S
• NCT07503210Phase 3 Novo Nordisk A/S
• NCT07581431Phase 1 InSilico Medicine Hong Kong Limited

Oesophageal Cancer

10 recruiting in Australia

• NCT02198976Not Applicable Professor Michael Bourke
• NCT03222635Not Applicable Amsterdam UMC
• NCT05910827Phase 2 Hummingbird Bioscience
• NCT05914116Phase 2 DualityBio Inc.
• NCT06290505Phase 2 Australasian Gastro-Intestinal Trials Group
• NCT07217938Phase 2 Peter MacCallum Cancer Centre, Australia
• NCT07221149Phase 3 Bristol-Myers Squibb
• NCT07334119Phase 1 Myeloid Therapeutics
• NCT07341737Phase 2 Second Life Therapeutics
• NCT07431281Phase 3 AstraZeneca

Osteoarthritis

7 recruiting in Australia

• NCT04848896Not Applicable Smith & Nephew, Inc.
• NCT05946044Not Applicable Wake Forest University
• NCT06191848Phase 4 University of Melbourne
• NCT06917404Phase 3 Paradigm Biopharmaceuticals Ltd.
• NCT07338266Phase 1 Avidence Therapeutics
• NCT07509307Phase 3 Novo Nordisk A/S
• NCT07532070Not Applicable University of Sydney

Osteoporosis

2 recruiting in Australia

• NCT04608630Phase 2 Australian and New Zealand Intensive Care Research Centre
• NCT06487130Not Applicable Bespoke Clinical Research

Ovarian Cancer

28 recruiting in Australia

• NCT04294927Not Applicable University Medical Center Nijmegen
• NCT04516447Phase 1 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
• NCT05123482Phase 2 AstraZeneca
• NCT05128825Phase 2 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
• NCT05735080Phase 2 Incyclix Bio
• NCT05797168Phase 2 AstraZeneca
• NCT05867251Phase 2 Avenzo Therapeutics, Inc.
• NCT06023862Phase 2 Yonsei University
• NCT06072781Phase 3 Verastem, Inc.
• NCT06161025Phase 3 Daiichi Sankyo
• NCT06188520Phase 2 AstraZeneca
• NCT06234423Phase 1 OnCusp Therapeutics, Inc.
• NCT06365853Phase 2 AbbVie
• NCT06400472Phase 1 Eli Lilly and Company
• NCT06533332Phase 1 EtiraRx Australia Pty Ltd
• NCT06690775Phase 2 TORL Biotherapeutics, LLC
• NCT06751329Phase 1 Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
• NCT06819007Phase 3 Daiichi Sankyo
• NCT06953089Phase 2 DualityBio Inc.
• NCT07023627Phase 2 Incyte Corporation
• NCT07059845Phase 2 AbbVie
• NCT07214779Phase 3 Incyte Corporation
• NCT07218809Phase 3 AstraZeneca
• NCT07226427Phase 1 Stemline Therapeutics, Inc.
• NCT07286266Phase 3 GlaxoSmithKline
• NCT07318558Phase 3 Merck Sharp & Dohme LLC
• NCT07491081Not Applicable Queensland Centre for Gynaecological Cancer
• NCT07546500Phase 3 K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc

Pancreatic Cancer

23 recruiting in Australia

• NCT04429542Phase 1 Bicara Therapeutics
• NCT04924075Phase 2 Merck Sharp & Dohme LLC
• NCT04970056Not Applicable Arbor Research Collaborative for Health
• NCT05141149Phase 2 Prestige Biopharma Limited
• NCT05254171Phase 3 Panbela Therapeutics, Inc.
• NCT05417594Phase 2 AstraZeneca
• NCT06179160Phase 1 Incyte Corporation
• NCT06244771Phase 2 Frontier Medicines Corporation
• NCT06319755Not Applicable Royal Prince Alfred Hospital, Sydney, Australia
• NCT06345079Phase 2 Australasian Gastro-Intestinal Trials Group
• NCT06428409Phase 2 Merck Sharp & Dohme LLC
• NCT06885034Phase 2 GlaxoSmithKline
• NCT06907043Phase 2 Eikon Therapeutics
• NCT06914128Phase 2 Bayer
• NCT06917079Phase 1 TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
• NCT06943755Phase 3 Exelixis
• NCT06989437Phase 3 Pfizer
• NCT07020221Phase 2 Verastem, Inc.
• NCT07072728Phase 2 Psyence Australia Pty Ltd
• NCT07094113Phase 1 Amgen
• NCT07229313Phase 1 Kivu Bioscience Inc.
• NCT07562152Phase 3 Immuneering Corporation
• NCT07644559Phase 2 Verastem, Inc.

Pancreatitis

1 recruiting in Australia

• NCT06651580Not Applicable M.D. Anderson Cancer Center

Parkinson's Disease

19 recruiting in Australia

• NCT04071847Not Applicable Abbott Medical Devices
• NCT04643327Phase 2 The University of Queensland
• NCT06170788Phase 3 Merck Sharp & Dohme LLC
• NCT06345729Phase 3 Merck Sharp & Dohme LLC
• NCT06466525Phase 1 Longevity Biotech Australia Pty Ltd (subsidiary)
• NCT06623422Phase 3 Merck Sharp & Dohme LLC
• NCT06732180Phase 1 Gain Therapeutics, Inc.
• NCT06841354Phase 3 Merck Sharp & Dohme LLC
• NCT06944522Phase 3 BlueRock Therapeutics
• NCT06952504Phase 3 Merck Sharp & Dohme LLC
• NCT06966700Phase 3 Merck Sharp & Dohme LLC
• NCT06989112Phase 3 AstraZeneca
• NCT07057219Not Applicable The University of New South Wales
• NCT07147348Phase 2 BioNTech SE
• NCT07174310Phase 3 Hoffmann-La Roche
• NCT07422675Phase 1 Serina Therapeutics
• NCT07545473Not Applicable Center for Eye Research Australia
• NCT07630545Phase 1 Mission Therapeutics
• NCT07710885Phase 3 Taiho Pharmaceutical Co., Ltd.

Peripheral Arterial Disease

9 recruiting in Australia

• NCT01524276Not Applicable Medtronic
• NCT04573660Not Applicable Abbott Medical Devices
• NCT04584632Not Applicable Efemoral Medical, Inc.
• NCT04674969Not Applicable Boston Scientific Corporation
• NCT04774159Phase 3 Population Health Research Institute
• NCT05485961Phase 3 CSL Behring
• NCT06075940Not Applicable R3 Vascular Inc.
• NCT06410313Not Applicable Medinol Ltd.
• NCT07223593Phase 3 Eli Lilly and Company

Peripheral Neuropathy

11 recruiting in Australia

• NCT01193075Not Applicable Michael Shy
• NCT05005026Not Applicable Texas A&M University
• NCT05009394Not Applicable Prometei Pain Rehabilitation Center
• NCT05305430Not Applicable Synergy Spine Solutions
• NCT05971329Not Applicable Zetagen Therapeutics, Inc
• NCT06858579Phase 3 Dianthus Therapeutics
• NCT06961565Phase 1 Pasithea Therapeutics Corp.
• NCT07032662Phase 2 Immunovant Sciences GmbH
• NCT07064122Phase 1 AstraZeneca
• NCT07223203Phase 3 Alnylam Pharmaceuticals
• NCT07264270Phase 1 Consano Bio

Phenylketonuria

4 recruiting in Australia

• NCT06302348Phase 3 PTC Therapeutics
• NCT06628128Phase 3 Otsuka Pharmaceutical Development & Commercialization, Inc.
• NCT06971731Phase 3 Otsuka Pharmaceutical Development & Commercialization, Inc.
• NCT07446400Phase 1 Otsuka Pharmaceutical Development & Commercialization, Inc.

Primary Biliary Cholangitis

3 recruiting in Australia

• NCT06016842Phase 3 Ipsen
• NCT06051617Phase 3 Gilead Sciences
• NCT06447168Not Applicable Ipsen

Prostate Cancer

47 recruiting in Australia

• NCT03522064Phase 2 St Vincent's Hospital, Sydney
• NCT04221542Phase 1 Amgen
• NCT04606446Phase 2 Pfizer
• NCT05184790Not Applicable University of Sydney
• NCT05393791Phase 2 Leiden University Medical Center
• NCT05521412Phase 2 Peter MacCallum Cancer Centre, Australia
• NCT05560659Phase 2 Peter MacCallum Cancer Centre, Australia
• NCT05720130Phase 2 AdvanCell Pty Limited
• NCT05800665Phase 1 Genentech, Inc.
• NCT05818683Phase 1 Janssen Research & Development, LLC
• NCT05997615Phase 1 Vir Biotechnology, Inc.
• NCT06095089Phase 1 Janssen Research & Development, LLC
• NCT06136624Phase 3 Merck Sharp & Dohme LLC
• NCT06136650Phase 3 Merck Sharp & Dohme LLC
• NCT06267729Phase 2 AstraZeneca
• NCT06279260Not Applicable Melbourne Health
• NCT06353386Phase 2 Merck Sharp & Dohme LLC
• NCT06450106Phase 1 SURGE Therapeutics
• NCT06492122Phase 1 Full-Life Technologies UK Limited
• NCT06496256Not Applicable Palette Life Sciences, Inc.
• NCT06520345Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited
• NCT06547398Not Applicable Royal North Shore Hospital
• NCT06594926Phase 2 Australian and New Zealand Urogenital and Prostate Cancer Trials Group
• NCT06780670Phase 3 Novartis Pharmaceuticals
• NCT06784193Phase 1 Olema Pharmaceuticals, Inc.
• NCT06830850Phase 1 Atridia Pty Ltd.
• NCT06863272Phase 2 Merck Sharp & Dohme LLC
• NCT06879041Phase 1 AstraZeneca
• NCT06907641Phase 2 St Vincent's Hospital, Sydney
• NCT06952803Phase 3 AstraZeneca
• NCT06991556Phase 2 Novartis Pharmaceuticals
• NCT07028853Phase 3 Pfizer
• NCT07052214Phase 3 Telix Pharmaceuticals (Innovations) Pty Limited
• NCT07140900Phase 1 Amgen
• NCT07164443Phase 3 Janssen Research & Development, LLC
• NCT07223372Not Applicable Bayer
• NCT07225946Phase 3 Janssen Research & Development, LLC
• NCT07226986Phase 2 Novartis Pharmaceuticals
• NCT07259213Phase 2 Radiopharm Theranostics, Ltd
• NCT07277270Phase 1 GlaxoSmithKline
• NCT07287150Phase 2 Hoffmann-La Roche
• NCT07529717Phase 2 AstraZeneca
• NCT07552922Not Applicable St Vincent's Hospital, Sydney
• NCT07567846Phase 2 Genentech, Inc.
• NCT07570979Phase 1 Novartis Pharmaceuticals
• NCT07590934Phase 2 AstraZeneca
• NCT07608848Early Phase 1 Integrated Haematology and Oncology Network

Psoriasis

3 recruiting in Australia

• NCT04772079Phase 3 Bristol-Myers Squibb
• NCT06380907Phase 2 Zai Lab (Hong Kong), Ltd.
• NCT07116967Phase 3 Bristol-Myers Squibb

Psoriatic Arthritis

6 recruiting in Australia

• NCT03773965Phase 3 Eli Lilly and Company
• NCT06100744Phase 3 AbbVie
• NCT06663332Phase 3 Janssen Research & Development, LLC
• NCT06671496Phase 3 Takeda
• NCT06807424Phase 3 Janssen Research & Development, LLC
• NCT07455578Phase 1 Seismic Therapeutic AU Pty Ltd

PTSD

4 recruiting in Australia

• NCT06175104Not Applicable Children's Hospital Medical Center, Cincinnati
• NCT06412757Phase 3 Deakin University
• NCT07280065Phase 3 Senseye, Inc.
• NCT07499440Phase 2 HB BioTech, LLC

Pulmonary Hypertension

8 recruiting in Australia

• NCT05587712Phase 2 Merck Sharp & Dohme LLC
• NCT06649110Phase 2 Novartis Pharmaceuticals
• NCT07073820Phase 2 Pfizer
• NCT07175038Phase 2 AllRock Bio, Inc.
• NCT07179380Phase 3 Insmed Incorporated
• NCT07218029Phase 3 Merck Sharp & Dohme LLC
• NCT07318597Phase 2 Regeneron Pharmaceuticals
• NCT07623525Phase 2 Diagonal Therapeutics, Inc.

Rare Disease

8 recruiting in Australia

• NCT02560883Not Applicable Ohio State University Comprehensive Cancer Center
• NCT05589714Not Applicable Jaeb Center for Health Research
• NCT05607498Phase 1 EpimAb Biotherapeutics (Suzhou)Co., Ltd.
• NCT05967689Phase 2 Taiho Oncology, Inc.
• NCT06016946Not Applicable Friedreich's Ataxia Research Alliance
• NCT06706076Phase 2 BlossomHill Therapeutics
• NCT07039084Not Applicable Murdoch Childrens Research Institute
• NCT07185997Phase 3 ArriVent BioPharma, Inc.

Retinal Vein Occlusion and Diabetic Macular Oedema

1 recruiting in Australia

• NCT06701721Phase 1 Therini Bio Pty Ltd

Rheumatoid Arthritis

13 recruiting in Australia

• NCT02469662Not Applicable Zimmer Biomet
• NCT05638854Phase 1 Zenas BioPharma (USA), LLC
• NCT06108934Not Applicable Stryker Australia Pty Ltd.
• NCT06747949Phase 3 Amgen
• NCT06917742Phase 1 Capstan Therapeutics
• NCT07017686Not Applicable The Bionics Institute of Australia
• NCT07118241Phase 2 Lubris Bio Pty Ltd
• NCT07201558Phase 1 AstraZeneca
• NCT07207954Phase 1 Lifordi Immunotherapeutics, Inc.
• NCT07234773Phase 1 Kali Therapeutics, Inc.
• NCT07284797Phase 1 Xencor, Inc.
• NCT07295847Phase 1 AstraZeneca
• NCT07363590Phase 1 Merck Sharp & Dohme LLC

Schizophrenia

4 recruiting in Australia

• NCT04113993Phase 4 The Alfred
• NCT05982158Not Applicable Swinburne University of Technology
• NCT06947941Phase 3 Bristol-Myers Squibb
• NCT07424404Phase 3 Karuna Therapeutics, Inc., a Bristol Myers Squibb company

Sickle Cell Disease

1 recruiting in Australia

• NCT06612268Phase 3 Novo Nordisk A/S

Sleep Disorders

9 recruiting in Australia

• NCT05262439Not Applicable ResMed
• NCT05978505Phase 2 Flinders University
• NCT06567210Not Applicable Woolcock Institute of Medical Research
• NCT06769607Not Applicable ResMed
• NCT06801379Early Phase 1 Woolcock Institute of Medical Research
• NCT06802913Early Phase 1 Woolcock Institute of Medical Research
• NCT07026175Not Applicable Australian Catholic University
• NCT07369011Phase 3 Eli Lilly and Company
• NCT07571109Phase 3 Novo Nordisk A/S

Spinal Muscular Atrophy

4 recruiting in Australia

• NCT01793168Not Applicable Sanford Health
• NCT06764485Phase 3 Celgene
• NCT07190300Phase 2 Novartis Pharmaceuticals
• NCT07336446Phase 2 AstraZeneca

Stomach Cancer

27 recruiting in Australia

• NCT04895709Phase 2 Bristol-Myers Squibb
• NCT05150691Phase 2 DualityBio Inc.
• NCT05267626Phase 2 Aulos Bioscience, Inc.
• NCT05427487Phase 1 ImmVirx Pty Ltd
• NCT05523947Phase 2 Yuhan Corporation
• NCT05581004Phase 1 Genentech, Inc.
• NCT05804331Not Applicable Western Sydney Local Health District
• NCT05872295Phase 1 Iksuda Therapeutics Ltd.
• NCT05969041Phase 1 Myeloid Therapeutics
• NCT06219941Phase 2 AstraZeneca
• NCT06242470Phase 1 MacroGenics
• NCT06330064Phase 2 Daiichi Sankyo
• NCT06337084Phase 1 Monopar Therapeutics
• NCT06532006Phase 3 Shanghai Henlius Biotech
• NCT06617169Phase 1 Monopar Therapeutics
• NCT06730750Phase 2 Bristol-Myers Squibb
• NCT06731478Phase 3 Daiichi Sankyo
• NCT06760819Phase 2 Bayer
• NCT06764875Phase 3 AstraZeneca
• NCT06789172Phase 1 Epkin
• NCT06901531Phase 3 Astellas Pharma Global Development, Inc.
• NCT06910657Phase 1 ViroMissile, Inc.
• NCT06921837Phase 2 Bolt Biotherapeutics, Inc.
• NCT06974110Phase 1 MOMA Therapeutics
• NCT07070232Phase 2 BioNTech SE
• NCT07115043Phase 2 AstraZeneca
• NCT07262619Phase 2 Eikon Therapeutics

Stroke

16 recruiting in Australia

• NCT04075084Not Applicable Biotronik SE & Co. KG
• NCT04434807Not Applicable University of Melbourne
• NCT05105633Phase 3 University of Melbourne
• NCT05892510Phase 3 University of Melbourne
• NCT05951101Not Applicable AuriGen Medical Ltd
• NCT06148051Not Applicable Perminder Sachdev
• NCT06226805Phase 2 Basking Biosciences, Inc.
• NCT06320431Phase 3 University of Calgary
• NCT06352619Not Applicable The George Institute
• NCT06352632Phase 3 The George Institute
• NCT06429332Phase 4 Region Skane
• NCT06763055Phase 3 The George Institute
• NCT06813651Phase 2 ThromBio Pty. Ltd.
• NCT06962371Not Applicable Transverse Medical, Inc.
• NCT06999122Not Applicable EMVision Medical Devices Ltd
• NCT07371455Phase 1 Longwood Pharmaceuticals (Hangzhou) Co., Ltd.

Thyroid Cancer

5 recruiting in Australia

• NCT03093116Phase 2 Turning Point Therapeutics, Inc.
• NCT03175224Phase 2 Apollomics Inc.
• NCT05024929Not Applicable Children's Hospital of Philadelphia
• NCT05503797Phase 2 Fore Biotherapeutics
• NCT05538130Phase 1 Pfizer

Transverse Myelitis

1 recruiting in Australia

• NCT06312644Not Applicable Alexion Pharmaceuticals, Inc.

Tuberculosis

1 recruiting in Australia

• NCT03474029Phase 3 Centers for Disease Control and Prevention

Type 1 Diabetes

11 recruiting in Australia

• NCT00097292Not Applicable University of South Florida
• NCT06324604Phase 1 Mozart Therapeutics Australia Pty Ltd
• NCT06325202Not Applicable Milton S. Hershey Medical Center
• NCT06937203Phase 2 Arrowhead Pharmaceuticals
• NCT07076199Phase 3 Novo Nordisk A/S
• NCT07088068Phase 3 Sanofi
• NCT07187531Phase 2 SAb Biotherapeutics, Inc.
• NCT07222137Phase 3 Eli Lilly and Company
• NCT07222332Phase 3 Eli Lilly and Company
• NCT07228117Not Applicable Medtronic MiniMed, Inc.
• NCT07564414Phase 3 Novo Nordisk A/S

Type 2 Diabetes

13 recruiting in Australia

• NCT05142189Phase 1 BioNTech SE
• NCT05633810Phase 3 Montreal Heart Institute
• NCT06267391Not Applicable Endogenex, Inc.
• NCT06579404Not Applicable University of Cambridge
• NCT06908486Not Applicable University of Sydney
• NCT06942195Not Applicable University of Adelaide
• NCT07091162Not Applicable Monash University
• NCT07098663Phase 2 Mankind Pharma Limited
• NCT07215559Phase 2 Eli Lilly and Company
• NCT07351045Phase 3 Hoffmann-La Roche
• NCT07351058Phase 3 Hoffmann-La Roche
• NCT07392190Phase 3 Eli Lilly and Company
• NCT07662213Phase 3 AstraZeneca

Uveitis

3 recruiting in Australia

• NCT05200715Not Applicable University of Siena
• NCT06371417Phase 1 Chugai Pharmaceutical
• NCT06395285Phase 1 Shanghai Yao Yuan Biotechnology Ltd. (also known as Drug Farm)

Vasculitis

2 recruiting in Australia

• NCT06733935Phase 2 Nkarta, Inc.
• NCT07160608Phase 2 Alexion Pharmaceuticals, Inc.

Vitiligo

2 recruiting in Australia

• NCT06905873Phase 1 Forte Biosciences, Inc.
• NCT07431177Phase 2 Novartis Pharmaceuticals

Not medical advice. Information on this site does not constitute medical advice. Data is sourced from publicly available government registries. Trial status can change; always verify current status directly with the trial site before making any decision. Verify Australian availability with your doctor.